Levente Doleviczényi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Levente Doleviczényi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Anett Rancz
Centre for Translational Medicine, Semmelweis University, Budapest, Hungary
1 shared publicationBoglárka Lilla Szentes
Centre for Translational Medicine, Semmelweis University, Budapest, Hungary
1 shared publicationDóra Léna Fedorcsák
Centre for Translational Medicine, Semmelweis University, Budapest, Hungary
1 shared publication- Lőrinc Frivaldszky
Centre for Translational Medicine, Semmelweis University, Budapest, Hungary
1 shared publication Péter Hegyi
Centre for Translational Medicine, Semmelweis University, Budapest, Hungary
1 shared publication- Zoltán Klárik
Centre for Translational Medicine, Semmelweis University, Budapest, Hungary
1 shared publication
Latest Publications
- Open Access
- 25 November 2025
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 215 (1) , 13
The significance of perioperative glucocorticoids in the prevention of seroma formation after mastectomies: a systematic review and meta-analysis
Purpose: Seroma formation is one of the most common complications after mastectomy. Seromas can lead to repeated aspirations, increase the risk of infection, and potentially delay oncologic treatment. Several strategies have recently been employed to prevent seromas, but there is no definitive standard. We aim to determine whether perioperative glucocorticoids (GC) are safe and effective in preventing seromas in patients undergoing mastectomy. Methods: We performed a systematic search in five databases on November 12, 2024. Eligible studies included women who underwent mastectomy and received perioperative GCs. Results are reported as risk ratios (RR), odds ratios (OR), or mean differences (MDs) with 95% confidence intervals (CIs), and are presented as forest plots. A random-effects model was used to pool effect sizes. Results: Altogether, 13 studies (12 RCTs and 1 case–control study) with 1011 patients were included; all were eligible for meta-analysis. The rate of seroma formation was significantly lower in the GC groups compared to the placebo groups (RR = 0.56, CI 0.38; 0.82, p = 0,008). Total volume of drainage (MD = -213.36 ml, CI -312.5; -114.22, p = 0.001) and days to drain removal (MD =—3.01 days, CI -4.06; -1.96, p = 0.001) were also lower in the GC groups. The rate of wound infection showed a higher trend in the intervention groups (RR = 1.26, CI 0.82; 1.92, p = 0.224), although the results did not reach statistical significance, Conclusions: Our results suggest that perioperative glucocorticoid administration may reduce seroma formation in patients undergoing mastectomy. A potential increase in wound infection rates was also observed, but this requires further investigation.
- 25 November 2025
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 215 (1) , 13
Open AccessThe significance of perioperative glucocorticoids in the prevention of seroma formation after mastectomies: a systematic review and meta-analysis
Purpose: Seroma formation is one of the most common complications after mastectomy. Seromas can lead to repeated aspirations, increase the risk of infection, and potentially delay oncologic treatment. Several strategies have recently been employed to prevent seromas, but there is no definitive standard. We aim to determine whether perioperative glucocorticoids (GC) are safe and effective in preventing seromas in patients undergoing mastectomy. Methods: We performed a systematic search in five databases on November 12, 2024. Eligible studies included women who underwent mastectomy and received perioperative GCs. Results are reported as risk ratios (RR), odds ratios (OR), or mean differences (MDs) with 95% confidence intervals (CIs), and are presented as forest plots. A random-effects model was used to pool effect sizes. Results: Altogether, 13 studies (12 RCTs and 1 case–control study) with 1011 patients were included; all were eligible for meta-analysis. The rate of seroma formation was significantly lower in the GC groups compared to the placebo groups (RR = 0.56, CI 0.38; 0.82, p = 0,008). Total volume of drainage (MD = -213.36 ml, CI -312.5; -114.22, p = 0.001) and days to drain removal (MD =—3.01 days, CI -4.06; -1.96, p = 0.001) were also lower in the GC groups. The rate of wound infection showed a higher trend in the intervention groups (RR = 1.26, CI 0.82; 1.92, p = 0.224), although the results did not reach statistical significance, Conclusions: Our results suggest that perioperative glucocorticoid administration may reduce seroma formation in patients undergoing mastectomy. A potential increase in wound infection rates was also observed, but this requires further investigation.